Fellows of the British Pharmacological Society are members who have demonstrated distinction and peer recognition in pharmacology.
Fellows have made, and may continue to make, substantial contributions to the disciplines of pharmacology, clinical pharmacology and therapeutics, through their work, publication and presentation of research, leadership, and contribution to Society life.
Find out more and apply for Fellowship.
This directory has been created to increase the visibility of our Fellows and their contributions, and to support networking by providing a useful resource for members to connect with Fellows with similar areas of interest.
Here you can find profiles of each Fellow, including information on their institutional affiliation, year elected, primary professional setting, affinity group membership, and a short biography.
Select the magnifying glass icon to begin any searches.
Dr Edwards obtained his PhD from the University of Manchester in 1979 after graduating with Honours in Biochemistry from the University of Birmingham in 1975.
Honorary Lecturer, The University of Manchester; previously Lecturer in Molecular Pharmacology 2002–2016.
Ahmed El-Hashim obtained his BSc (1993) and completed his PhD (1997) in Pharmacology from King’s College London, before joining Novartis Pharma as a post-doctoral fellow where he worked in late pre-clinical drug discovery and development of animal models of respiratory disease.
Dr Jane Escott is a Senior Director at AstraZeneca, who has contributed to the development of new therapeutics over her 20 years in the Pharmaceutical Industry.
Professor Evans developed an interest in Pharmacology when working as a research technician at Beecham Pharmaceuticals.
Anthony Fenech obtained his PhD in molecular pharmacology from the University of Nottingham in 2003, under the tutorship of Professor Ian Hall.
Albert Ferro studied Medicine at King’s College London (1978-1984), obtaining a 1st Class Honours intercalated BSc degree in Biochemistry in 1981 along the way.
Susan M Fleetwood-Walker (Personal Chair in Sensory Neuroscience, Edinburgh) uses pharmacological, physiological, biochemical and molecular tools to identify key receptors, protein:protein interactions and signalling events in pain processing in order to identify novel therapeutic opportunities for analgesics that can reverse intractable pain states.